drugset / Trial / NCT03222544

Clinical Study of Methylene Blue - Mediated Photodynamic Therapy for Diabetic Lower Limb Ulcer

NCT03222544

Unknown 60 enrolled Chongqing Medical University
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators designed this prospective, randomized control study to confirm the efficacy and safety of methylene blue - mediated photodynamic therapy for diabetic lower limb ulcer and to explore its mechanism.

Timeline

Start
2019-04-29
Primary completion
2020-04-29
Completion
2020-06-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylene Blue Diagnostic / imaging agent Topical

Indications